CY1108785T1 - Σταθερη φαρμακευτικη γελη diclofenac na - Google Patents
Σταθερη φαρμακευτικη γελη diclofenac naInfo
- Publication number
- CY1108785T1 CY1108785T1 CY20081101232T CY081101232T CY1108785T1 CY 1108785 T1 CY1108785 T1 CY 1108785T1 CY 20081101232 T CY20081101232 T CY 20081101232T CY 081101232 T CY081101232 T CY 081101232T CY 1108785 T1 CY1108785 T1 CY 1108785T1
- Authority
- CY
- Cyprus
- Prior art keywords
- diclofenac
- medicinal gel
- stable medicinal
- composition
- gel diclofenac
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Σύνθεση γέλης για τοπική χορήγηση Diclofenac μέσω του δέρματος περιέχει Diclofenac Na σε συγκέντρωση περίπου 1% και ένα μίγμα propylene glycol και methocel σε αναλογία μεταξύ 6 και 2. Η σύνθεση περιέχει επίσης φαρμακευτικώς αποδεκτά έκδοχα. Ο κατάλληλος περιέκτης και διαδικασία για την παρασκευή της εν λόγω σύνθεσης περιγράφονται επίσης.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/GR2005/000023 WO2006134406A1 (en) | 2005-06-14 | 2005-06-14 | Stable pharmaceutical gel of diclofenac sodium |
EP05749611A EP1890687B1 (en) | 2005-06-14 | 2005-06-14 | Stable pharmaceutical gel of diclofenac sodium |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1108785T1 true CY1108785T1 (el) | 2014-04-09 |
Family
ID=35788029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081101232T CY1108785T1 (el) | 2005-06-14 | 2008-10-31 | Σταθερη φαρμακευτικη γελη diclofenac na |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1890687B1 (el) |
CY (1) | CY1108785T1 (el) |
RS (1) | RS50693B (el) |
WO (1) | WO2006134406A1 (el) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2143421A1 (en) * | 2008-07-07 | 2010-01-13 | Almirall Hermal GmbH | Topical composition for the treatment of actinic keratosis |
DE202010012255U1 (de) * | 2010-09-07 | 2010-11-18 | Krewel Meuselbach Gmbh | Nasenspray |
US9468618B2 (en) * | 2014-12-12 | 2016-10-18 | Lupin Atlantis Holdings Sa | Topical pharmaceutical gel composition of diclofenac sodium |
US9468617B2 (en) * | 2014-12-12 | 2016-10-18 | Lupin Atlantis Holdings Sa | Topical pharmaceutical gel composition of diclofenac sodium |
US9687549B2 (en) * | 2015-03-14 | 2017-06-27 | Lupin Atlantis Holdings Sa | Topical pharmaceutical gel composition of diclofenac sodium |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4670254A (en) * | 1983-12-09 | 1987-06-02 | Toko Yakuhin Industry Co., Ltd. | Gel preparations for topical application of diclofenac sodium |
EP0450123B1 (de) * | 1990-04-05 | 1995-07-05 | Knoll AG | Diclofenac-Natrium enthaltende pharmazeutische Zusammensetzung zur topischen Anwendung |
JP3086290B2 (ja) * | 1991-07-26 | 2000-09-11 | エスエス製薬株式会社 | ジクロフェナクナトリウム貼付剤 |
GB9902227D0 (en) * | 1999-02-01 | 1999-03-24 | Cipla Limited | Pharmaceutical composition for topical administration |
PL367337A1 (en) * | 2001-05-31 | 2005-02-21 | Pharmacia Corporation | Skin-permeable selective cyclooxygenase-2 inhibitor composition |
WO2005027977A2 (en) * | 2003-09-22 | 2005-03-31 | Agis Industries (1983) Ltd. | Diclofenac compositions for the treatment of skin disorders |
-
2005
- 2005-06-14 EP EP05749611A patent/EP1890687B1/en active Active
- 2005-06-14 WO PCT/GR2005/000023 patent/WO2006134406A1/en active Application Filing
- 2005-06-14 RS RSP-2008/0570A patent/RS50693B/sr unknown
-
2008
- 2008-10-31 CY CY20081101232T patent/CY1108785T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
RS50693B (sr) | 2010-06-30 |
EP1890687A1 (en) | 2008-02-27 |
EP1890687B1 (en) | 2008-09-17 |
WO2006134406A1 (en) | 2006-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR037592A1 (es) | Formulaciones farmaceuticas de 5,7,14-triazatetraciclo (10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaeno | |
CY1119865T1 (el) | Φαρμακευτικες συνθεσεις για την αντιμετωπιση της νοσου του παρκινσον | |
AR022252A1 (es) | Composicion de administracion oral. | |
EA200701913A1 (ru) | Лечение статином, омега-3 жирными кислотами и их комбинированным продуктом | |
CY1118474T1 (el) | Φαρμακευτικες συνθεσεις που περιεχουν τοπικο αναισθητικο οπως η βουπιβακαϊνη για τοπικη χορηγηση στο στομα ή τον φαρυγγα | |
CY1115484T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson | |
AR023806A1 (es) | Uso de una mezcla de peptidos para la manufactura de un agente terapeutico para la profilaxis y/o el tratamiento del cancer, las composicionesfarmaceuticas y vacunas que contienen dicha mezcla y los procedimientos de preparacion de dichas composiciones y vacunas | |
MX2009004203A (es) | Combinaciones de paracetamol/ibuprofeno y metodo para su uso. | |
CO6331425A2 (es) | Composiciones que comprenden n-(3,4-difluoro-2-(2-fluoro-4-yodofenilamino)6-metoxifenil)-1-(2,3-dihidroxiproxipropil)ciclopropan-1-sulfamida | |
GT200600163A (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de la depresion | |
UY26052A1 (es) | Composiciones analgesicas que comprenden compuestos antiepilepticos y metodos para usarlas | |
EE200300033A (et) | Tsüklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon | |
ES2109899T1 (es) | Metodo, composiciones y kits para aumentar la biodisponibilidad oral de agentes farmaceuticos. | |
ATE543491T1 (de) | Kombinationspräparat enthaltend ibuprofen und paracetamol | |
ECSP034571A (es) | Nuevas composiciones de medicamentos a base de sales de tiotropio y sales del salmeterol | |
TW200603787A (en) | Topical preparations containing ambroxol | |
CY1108785T1 (el) | Σταθερη φαρμακευτικη γελη diclofenac na | |
PE20081799A1 (es) | Mejoras en composiciones medicinales o relativas a las mismas | |
DE60205905D1 (de) | Pharmazeutische zusammensetzung zur orale verabreichung mit verbesserter bioverfügbarkeit | |
CO2022015428A2 (es) | Compuesto de oxofenilarsina deuterada y uso del mismo | |
AR065582A1 (es) | Mejoras en composiciones medicinales o relativas a las mismas | |
AR036755A1 (es) | Una composicion en forma de gel transparente para la administracion de diclofenac sodico a traves de la piel | |
UY29201A1 (es) | Sistema de aplicacion localizada y residual de medicamentos intra oral | |
HN2010001775A (es) | Composicion farmaceutica oral que comprende la combinacion de una sal de keterolaco y vitaminas del complejo b | |
EA201290378A1 (ru) | Композиции, содержащие нестероидные противовоспалительные лекарственные средства |